Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Adenocarcinoma of Lung 2 Uterine Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Radiomics 1 Prostatic Neoplasms 1 Pituitary Diseases 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neuroendocrine Tumors 1 Lung Neoplasms 1 Lung Diseases 1 Liver Cirrhosis 1 Hepatitis B 1 Head and Neck Neoplasms 1 Disease Progression 1 Carcinoma, Squamous Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Lobular 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms 1 Bone Neoplasms 1

Interventions

Gemcitabine 7 Doxorubicin 4 Cyclophosphamide 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Docetaxel 3 Cisplatin 3 regorafenib 2 Vincristine 2 Tranexamic Acid 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Radiation 2 Proton Therapy 2 Nivolumab 2 Methotrexate 2 Methods 2 Interviews as Topic 2 Indocyanine Green 2 Everolimus 2 Curettage 2 Ascorbic Acid 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 tocilizumab 1 samarium Sm-153 lexidronam 1 poly ICLC 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Bone Neoplasms × Radiomics × Clear all

NCT04955522 2021-07-08

Multimodal Imaging Analysis of Spinal Tumors

Peking University Third Hospital

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡